Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials (Q3576931)

From MaRDI portal
Revision as of 03:33, 5 February 2024 by Import240129110113 (talk | contribs) (Added link to MaRDI item.)
scientific article
Language Label Description Also known as
English
Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials
scientific article

    Statements

    Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    3 August 2010
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    adaptive design
    0 references
    Bayesian design
    0 references
    clinical trial
    0 references
    combination dose finding
    0 references
    utility
    0 references